Explore a new investigational treatment option for #postpartum depression at Sunstone. Learn if participating in a research study is an option for you. Compensation Included. See if this trial is right for you : https://lnkd.in/e2GpRy7u
Sunstone Therapies
心理健康保健
Rockville，Maryland 2,202 位关注者
Leading the research and delivery of psychedelic therapies for those affected by complex mental health challenges.
关于我们
Sunstone is a leader in the delivery of psychedelic-assisted therapy in the medical setting, focusing on the development and execution of clinical trials today, and moving towards clinical delivery when therapies are approved. We aim to reduce the emotional suffering of those affected by cancer and complex mental health challenges and disorders, and to make safe, effective psychedelic-assisted therapy an accessible reality for all who might benefit from it. Fundamental to our approach is the belief that health is not just the absence of illness but a state of emotional, social, and spiritual well-being. In the last 12 months, Sunstone has treated more patients with PAT (not including ketamine) within a clinical setting than any other organization in the world. Delivery of psychedelic therapies is complex, requiring significant capabilities and experience in logistics, infrastructure and training, as well as clinical care. Sunstone’s patient-centric approach is based on the cancer care model, with the team drawing on their deep experience in oncology to provide the operational excellence to deliver complex, multi-faceted care at scale. Sunstone also provides training and education in PAT, as well as focusing on all aspects of clinic design and delivery including digital platforms, cost modeling, and quality of care.
- 网站
-
https://sunstonetherapies.com
Sunstone Therapies的外部链接
- 所属行业
- 心理健康保健
- 规模
- 11-50 人
- 总部
- Rockville，Maryland
- 类型
- 私人持股
- 创立
- 2020
地点
-
主要
获取路线
9905 Medical Center Drive
#350
US，Maryland，Rockville，20850
Sunstone Therapies员工
动态
-
The field of psychedelic research and its potential therapeutic applications is rapidly evolving, and our new series aims to be at the forefront of this exciting area. By combining perspectives from multiple healthcare disciplines, we're offering a truly comprehensive and interdisciplinary approach to this emerging field of study. There's still time to join Sunstone Therapies CEO Dr. Manish Agrawal & Therapist Program Director Rachel Winzer for insights on psychedelic therapy research. Register now, https://ow.ly/9iOr50TZgCW. >> CEUs Available! >> Nursing Continuing Professional Development #UMSSW hashtag#UMSON hashtag#UMSOP hashtag#PsychedelicTherapy
-
-
Are psychedelic researchers finding trial recruitment challenging? That’s the question Jules Evans raised in his recent article. Sunstone’s CEO, Dr. Manish Agrawal, shares his perspective: "Patients know when something feels wrong and may have a sincere desire to explore new treatments, but they may not align with the rigid criteria of research protocols—criteria that do not fully reflect the nuanced reality of living with mental illness. This disconnect can make recruitment a complex process, and it highlights the need for diagnostic advancements that better bridge the gap between clinical research and real-world experiences." Read the full article here: https://lnkd.in/etPUSQSZ
-
On Veterans Day, we honor our Veterans and acknowledge the pressing mental health challenges many face. PTSD and other mental health conditions affect Veterans at disproportionately high rates, with suicide rates over 1.5x higher than civilians. At Sunstone Therapies, we’re committed to advancing innovative treatments that provide relief beyond traditional therapy and support deep healing, targeting trauma in ways that foster empathy, connection, and resilience—bringing our Veterans all the way home. Join us in supporting and honoring our Veterans today and every day. -- Mark Bates Robert Koffman #VeteransDay #VeteranCare #PsychedelicResearch
-
-
Two Sunstone therapists uniquely qualified to treat Veterans, Mark Bates and Robert Koffman, helped spearhead and subsequently co-author “The Epidemiology of Psychedelic Use Among United States Military Veterans” in collaboration with Alan Davis, PhD, Erik Lund, Nathan Sepeda, Dr. Adam Levin, Dr. Stacey Bradbury Armstrong, Katinka Hooyer, and Rachel Yehuda that was recently published in the Journal of Psychoactive Drugs. This survey study delves into veteran’s perspectives on psychedelic therapy and provides valuable insight into how veterans view and engage with psychedelic therapy.?In particular, the study highlights a significant shift: veterans are no longer content with approaches that merely manage symptoms. Instead, they’re seeking out therapies that promise deeper healing and meaningful transformation. The growing body of research into psychedelic-assisted therapy is providing valuable insights into its potential benefits and risks. Read about the full findings here: https://lnkd.in/eSDmETuA #veterancare #psychedelicresearch #OSU
-
-
Sunstone Therapist, Mark Bates, is presenting ‘Enhancing Holistic Care and Quality of Life: Psychedelic-Assisted Therapy for People with Cancer & Existential Distress’ at the Aging Life Care Association Mid-Atlantic Chapter Conference this Monday, November 4. Both Sunstone and the Aging Life Care Association are dedicated to enhancing quality of life through whole-person care. We’re excited to share our work conducting psychedelic-assisted therapy clinical trials for complex mental challenges with a community equally dedicated to advancing compassionate, integrative care. #WholePersonHealing #integrativecare #psychedelicresearch
-
-
Sunstone’s therapist, Jess M. Jones, was recently featured as a spotlight trainer at Fluence. Jess brings exceptional skill and compassion not only to her work supporting patients through clinical trials, but also in training healthcare professionals to deliver this specialized care. Listen to the full spotlight below.
Meet Jess M. Jones?full time staff therapist for psychedelic clinical trials at Sunstone Therapies and expert Fluence trainer! Jess has been focused on training therapist in clinical trials ensuring the highest standards. She is certified in TF-CBT, EMDR, and priCARE and previously had a private practice offering KAP and serving BIPOC, Spanish-speaking, and LGBTQ+ patients. She is also a MAPS certified therapist and consultant for MDMA-Assisted Therapy. Jess is passionate about equity and access to underserved communities and helps her students understand the wider view of psychedelic therapy and how they can be ambassadors for the field. Learn more about the Fluence team: https://hubs.li/Q02TCC2Q0
-
Sunstone is pleased to share that our CEO, Dr. Manish Agrawal, joined the recent Edge of Medicine Conference hosted by the Steven & Alexandra Cohen Foundation's Health Consortium. Thank you to the Cohen Foundation for creating this forum for conversations about implementing innovative and practical solutions into modern medicine and care.
True to its name, the Edge of Medicine Conference, hosted by the Steven & Alexandra Cohen Foundation's Health Consortium, fostered thought-provoking, solution-oriented discussions on the state of modern medicine. It was a privilege to join the discussions and engage with innovative, forward-thinking individuals dedicated to addressing complex issues with creative, out-of-the-box solutions. Thank you, Bennett Nemser and The Cohen Foundation for creating an important forum to problem solve areas of medicine that are not always asked about in traditional medicine.
-
-
We’re pleased to announce that Sunstone Therapies' CEO and Co-Founder, Dr. Manish Agrawal, was appointed to the Maryland Task Force on Responsible Use of Natural Psychedelic Substances. We at Sunstone have seen first-hand the transformative power that psychedelic substances can have on patients when administered in a safe and clinical setting. This appointment from Gov. Wes Moore recognizes Dr. Agrawal’s leadership in creating safe and effective patient access to psychedelics. As a member of the Maryland Task Force on Responsible Use of Natural Psychedelic Substances, Dr. Agrawal will share his unique perspective and deep experience in psychedelic treatment on the state’s consideration of the public benefits of responsible access to these medicines. We’re excited for this next step of creating the gold standard for psychedelic-assisted therapies. #PsychedelicTaskForce #GovWesMoore #PsychedelicTherapy
I’m proud to share that I was recently appointed to the Maryland Task Force on Responsible Use of Natural Psychedelic Substances by Gov. Wes Moore. An oncologist by training, I became interested in the potential of psychedelic medicines to help cancer patients heal from the mental toll of their cancer diagnosis. Now, almost five years later, I know first hand how impactful psychedelic-assisted therapy can be on mental health when administered in a safe and clinical setting. I am looking forward to partnering with experts from all over the state to determine how we may be able to adapt current laws, policies, and practices so that we can potentially bring these life-changing medicines to more patients who live with complex mental health conditions. My deepest thanks to Governor Moore and to the Maryland Legislature for this opportunity and for recognizing the importance of tackling this issue. I’m excited to continue my work leading Sunstone Therapies to set the gold-standard for psychedelic-assisted therapies. https://lnkd.in/dT2upvRu
Psychedelic Substances, Maryland Task Force on Responsible Use of Natural
msa.maryland.gov
-
Healthcare providers...Join Drs. Manish Agrawal and Rajan Dunne this Wednesday, October 23 from 12:30 - 1:15 pm for a virtual webinar that will cover the basics of psychedelic therapy, clinical trials underway at Sunstone, criteria for patient eligibility, and include time for Q&As. Please click here to RSVP: https://lnkd.in/eRw652Tu
-